Overview
Raquel Herranz practices practicing medicine in Valencia, Spain.
Her clinical expertise encompasses Bladder Cancer, Ovarian Cancer, Thrombocytopenia, and Lupus Nephritis.
She is actively involved in clinical research, co-authoring 16 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Raquel Herranz
Is Raquel Herranz a top-rated expert for Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Raquel Herranz is classified as an Experienced expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Raquel Herranz participate in research or clinical trials?
Yes. Raquel Herranz has published 16 articles and abstracts on conditions like Bladder Cancer. You can view a list of Raquel Herranz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bladder CancerMs. Herranz isExperienced. Learn about Bladder Cancer.
- Lupus NephritisMs. Herranz isExperienced. Learn about Lupus Nephritis.
- Ovarian CancerMs. Herranz isExperienced. Learn about Ovarian Cancer.
- ThrombocytopeniaMs. Herranz isExperienced. Learn about Thrombocytopenia.